Funded Tech Companies

Delcath Systems

Headquartered in New York,, Delcath Systems has funding from BVF Partners, Vivo Capital and Serrado Capital.

Company Overview

Contact Information

Company Background Information

Overview

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. At Delcath, we look beyond the ordinary and strive for excellence in all that we do. Our investigational product, HEPZATO� KIT (melphalan hydrochloride for injection/hepatic delivery system), is designed to administer high-dose chemotherapy to the liver, while controlling systemic exposure and associated side effects.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/28/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gerard Michel

        

Chief Operating Officer

John Purpura

        

Vice President

Johnny John

        

Vice President

Kevin Muir

        

Company Investors

• BVF Partners
• Vivo Capital
• Serrado Capital
• Stonepine Capital Management
• Rosalind Capital
• Logos Capital

Browse more funded tech companies:

Dekrypt Capital | Delectable

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary